Literature DB >> 9606180

A role for HLA-DO as a co-chaperone of HLA-DM in peptide loading of MHC class II molecules.

H Kropshofer1, A B Vogt, C Thery, E A Armandola, B C Li, G Moldenhauer, S Amigorena, G J Hämmerling.   

Abstract

In B cells, the non-classical human leukocyte antigens HLA-DO (DO) and HLA-DM (DM) are residents of lysosome-like organelles where they form tight complexes. DM catalyzes the removal of invariant chain-derived CLIP peptides from classical major histocompatibility complex (MHC) class II molecules, chaperones them until peptides are available for loading, and functions as a peptide editor. Here we show that DO preferentially promotes loading of MHC class II molecules that are dependent on the chaperone activity of DM, and influences editing in a positive way for some peptides and negatively for others. In acidic compartments, DO is engaged in DR-DM-DO complexes whose physiological relevance is indicated by the observation that at lysosomal pH DM-DO stabilizes empty class II molecules more efficiently than DM alone. Moreover, expression of DO in a melanoma cell line favors loading of high-stability peptides. Thus, DO appears to act as a co-chaperone of DM, thereby controlling the quality of antigenic peptides to be presented on the cell surface.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606180      PMCID: PMC1170637          DOI: 10.1093/emboj/17.11.2971

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Kinetic analysis of peptide loading onto HLA-DR molecules mediated by HLA-DM.

Authors:  A B Vogt; H Kropshofer; G Moldenhauer; G J Hämmerling
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

2.  HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes.

Authors:  P H Schafer; J M Green; S Malapati; L Gu; S K Pierce
Journal:  J Immunol       Date:  1996-12-15       Impact factor: 5.422

3.  HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport.

Authors:  M Liljedahl; T Kuwana; W P Fung-Leung; M R Jackson; P A Peterson; L Karlsson
Journal:  EMBO J       Date:  1996-09-16       Impact factor: 11.598

4.  H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection.

Authors:  W D Martin; G G Hicks; S K Mendiratta; H I Leva; H E Ruley; L Van Kaer
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

5.  Editing of the HLA-DR-peptide repertoire by HLA-DM.

Authors:  H Kropshofer; A B Vogt; G Moldenhauer; J Hammer; J S Blum; G J Hämmerling
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

6.  Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.

Authors:  J F Katz; C Stebbins; E Appella; A J Sant
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

7.  Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.

Authors:  D A Weber; B D Evavold; P E Jensen
Journal:  Science       Date:  1996-10-25       Impact factor: 47.728

8.  Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway.

Authors:  T Miyazaki; P Wolf; S Tourne; C Waltzinger; A Dierich; N Barois; H Ploegh; C Benoist; D Mathis
Journal:  Cell       Date:  1996-02-23       Impact factor: 41.582

9.  Antigen presentation and T cell development in H2-M-deficient mice.

Authors:  W P Fung-Leung; C D Surh; M Liljedahl; J Pang; D Leturcq; P A Peterson; S R Webb; L Karlsson
Journal:  Science       Date:  1996-03-01       Impact factor: 47.728

10.  Human histocompatibility leukocyte antigen (HLA)-DM edits peptides presented by HLA-DR according to their ligand binding motifs.

Authors:  S M van Ham; U Grüneberg; G Malcherek; I Bröker; A Melms; J Trowsdale
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

View more
  34 in total

1.  Early endosomal maturation of MHC class II molecules independently of cysteine proteases and H-2DM.

Authors:  J A Villadangos; C Driessen; G P Shi; H A Chapman; H L Ploegh
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

Review 2.  The expression of HLA-DO (H2-O) in B lymphocytes.

Authors:  Xinjian Chen; Peter E Jensen
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

3.  A point mutation in the groove of HLA-DO allows egress from the endoplasmic reticulum independent of HLA-DM.

Authors:  Francis Deshaies; Alexandre Brunet; Djibril A Diallo; Lisa K Denzin; Angela Samaan; Jacques Thibodeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-22       Impact factor: 11.205

4.  Divergent patterns of selection on the DAB and DXB MHC class II loci in Xiphophorus fishes.

Authors:  Kyle Summers; Kelly E Roney; Jack da Silva; Gerald Capraro; Brandon J Cuthbertson; Steven Kazianis; Gil G Rosenthal; Michael J Ryan; Thomas J McConnell
Journal:  Genetica       Date:  2008-07-04       Impact factor: 1.082

Review 5.  MHC class II antigen presentation by dendritic cells regulated through endosomal sorting.

Authors:  Toine ten Broeke; Richard Wubbolts; Willem Stoorvogel
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-12-01       Impact factor: 10.005

6.  HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.

Authors:  Padma P Nanaware; Mollie M Jurewicz; John D Leszyk; Scott A Shaffer; Lawrence J Stern
Journal:  Mol Cell Proteomics       Date:  2018-12-20       Impact factor: 5.911

7.  Mapping the HLA-DO/HLA-DM complex by FRET and mutagenesis.

Authors:  Taejin Yoon; Henriette Macmillan; Sarah E Mortimer; Wei Jiang; Cornelia H Rinderknecht; Lawrence J Stern; Elizabeth D Mellins
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-25       Impact factor: 11.205

8.  Mechanisms regulating enhanced human leukocyte antigen class II-mediated CD4 + T cell recognition of human B-cell lymphoma by resveratrol.

Authors:  Faisal F Y Radwan; Lixia Zhang; Azim Hossain; Bently P Doonan; Jason M God; Azizul Haque
Journal:  Leuk Lymphoma       Date:  2011-10-24

Review 9.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

10.  Human Hepatitis B Viral Infection Outcomes Are Linked to Naturally Occurring Variants of HLA-DOA That Have Altered Function.

Authors:  Austin M Graves; Francesca Virdis; Eliot Morrison; Miguel Álvaro-Benito; Aly A Khan; Christian Freund; Tatyana V Golovkina; Lisa K Denzin
Journal:  J Immunol       Date:  2020-07-20       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.